Jane Henderson Insider Trading Transactions
Get free email notifications about insider trading for Jane Henderson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Henderson. Jane Henderson is Chief Financial Officer & CBO in PANACOS PHARMACEUTICALS, INC. ($VITX) and Chief Financial Officer, CBO in PANACOS PHARMACEUTICALS, INC. ($VITX) and Director in Ophthotech Corp. ($OPHT) and Director in Eleven Biotherapeutics, Inc. ($EBIO) and CFO & SVP, Corp. Dev. in Voyager Therapeutics, Inc. ($VYGR) and Sr. V.P. & CFO in Voyager Therapeutics, Inc. ($VYGR) and Sr. V.P. & CFO, Corp. Dev. in Voyager Therapeutics, Inc. ($VYGR) and Director in Akero Therapeutics, Inc. ($AKRO).
Latest Insider Trading Transactions of Jane Henderson
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, OPHT, VITX, SESN, VYGR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
Jun 11 2020 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
Jun 02 2020 | AKRO | Akero Therapeutics ... | Henderson Jane | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
May 08 2020 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
May 16 2019 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
Jul 11 2018 | OPHT | Ophthotech Corp. | Henderson Jane | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Option Exercise | M | 11.97 | 11,200 | 134,064 | 165,584 | |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Option Exercise | M | 11.97 | 19,900 | 238,203 | 176,784 | |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Sell | S | 20.52 | 11,200 | 229,824 | 0 | 11.2 K to 0 (-100.00 %) |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Buy | M | 11.97 | 11,200 | 134,064 | 11,200 | 0 to 11.2 K |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Sell | S | 21.07 | 19,900 | 419,293 | 0 | 19.9 K to 0 (-100.00 %) |
Mar 26 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO, Cor ... | Buy | M | 11.97 | 19,900 | 238,203 | 19,900 | 0 to 19.9 K |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Option Exercise | M | 11.97 | 1,900 | 22,743 | 196,684 | |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Option Exercise | M | 11.97 | 15,416 | 184,530 | 198,584 | |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Sell | S | 21.76 | 1,900 | 41,344 | 0 | 1.9 K to 0 (-100.00 %) |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Buy | M | 11.97 | 1,900 | 22,743 | 1,900 | 0 to 1.9 K |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Sell | S | 22.15 | 15,416 | 341,464 | 0 | 15.4 K to 0 (-100.00 %) |
Mar 20 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | CFO & SVP, Corp. De ... | Buy | M | 11.97 | 15,416 | 184,530 | 15,416 | 0 to 15.4 K |
Mar 09 2018 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO | Option Exercise | A | 28.72 | 65,000 | 1,866,800 | 65,000 | |
Jan 17 2018 | OPHT | Ophthotech Corp. | Henderson Jane | Director | Option Exercise | A | 2.85 | 32,000 | 91,200 | 32,000 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
Jan 05 2017 | VYGR | Voyager Therapeuti ... | Henderson Jane | Sr. V.P. & CFO | Option Exercise | A | 11.97 | 214,000 | 2,561,580 | 214,000 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
May 02 2008 | VITX | PANACOS PHARMACEUT ... | Henderson Jane | Chief Financial Off ... | Grant | A | 0.47 | 50,000 | 23,535 | 125,000 | 75 K to 125 K (+66.67 %) |
Jan 07 2008 | VITX | PANACOS PHARMACEUT ... | Henderson Jane | Chief Financial Off ... | Option Exercise | A | 0.77 | 400,000 | 308,000 | 400,000 | |
Jan 07 2008 | VITX | PANACOS PHARMACEUT ... | Henderson Jane | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Page: 1